Guilherme Rabinowits, Baptist Health Medical Group; Miami Cancer InstituteFollow
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma
Additional authors and institutional affiliations
This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
Future Oncology (London, England) (2020) 16(4):11-19
Available to all.
Since February 17, 2020
My Account |